申请人:Board of Trustees of MICHIGAN STATE UNIVERSITY
公开号:US20030232998A1
公开(公告)日:2003-12-18
A new class of imidazolines as 4-position acids or esters with very potent anti-inflammatory as well as antimicrobial activity is described. The synthesis of these imidazolines includes a multicomponent reaction applicable to a combinatorial synthetic approach. The combination of these two key characteristics provides an effective therapeutic drug in the treatment of septic shock as well as many other inflammatory (arthritis and asthma) and infectious disorders. The use of this novel class of non-steroidal agents as anti-inflammatory agents (for the treatment of asthma, etc.), antibacterial agents, and antiseptic agents is described. The compounds are also useful in the treatment of tumors (such as cancers). The imidazolines are potent inhibitors of the transcription factor NF-&kgr;B as well as potent activity against the Gram (+) bacterium. The compositions are also useful for treating autoimmune diseases and for inhibiting rejection of organ and tissue transplants.
描述了一类新型的咪唑啉化合物,作为4-位置酸或酯具有非常强大的抗炎和抗菌活性。这些咪唑啉的合成包括一种适用于组合合成方法的多组分反应。这两个关键特性的结合提供了一种有效的治疗药物,可用于治疗败血症休克以及许多其他炎症(如关节炎和哮喘)和传染性疾病。描述了这一新型非甾体类抗炎药物(用于治疗哮喘等)、抗菌药物和防腐剂的用途。这些化合物还可用于治疗肿瘤(如癌症)。咪唑啉是转录因子NF-κB的强效抑制剂,对革兰氏阳性细菌也具有强效活性。这些组合物还可用于治疗自身免疫性疾病,并抑制器官和组织移植的排斥。